GB1569558A - 1-iodo (or chloro)-3-3-protected hydroxy-w-bicycloalkyl-1-alkenes - Google Patents
1-iodo (or chloro)-3-3-protected hydroxy-w-bicycloalkyl-1-alkenes Download PDFInfo
- Publication number
- GB1569558A GB1569558A GB40081/78A GB4008178A GB1569558A GB 1569558 A GB1569558 A GB 1569558A GB 40081/78 A GB40081/78 A GB 40081/78A GB 4008178 A GB4008178 A GB 4008178A GB 1569558 A GB1569558 A GB 1569558A
- Authority
- GB
- United Kingdom
- Prior art keywords
- iodo
- bicyclol
- bicyclo
- value
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 22
- -1 1-ethoxyethyl Chemical group 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 125000006239 protecting group Chemical group 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- OHSJPLSEQNCRLW-UHFFFAOYSA-N triphenylmethyl radical Chemical compound C1=CC=CC=C1[C](C=1C=CC=CC=1)C1=CC=CC=C1 OHSJPLSEQNCRLW-UHFFFAOYSA-N 0.000 claims 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 38
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 31
- KXMTXZACPVCDMH-UHFFFAOYSA-N methyl 4-[5-(hydroxymethyl)-7-methoxy-1,3-benzodioxol-4-yl]-7-methoxy-1,3-benzodioxole-5-carboxylate Chemical compound COC(=O)C1=CC(OC)=C2OCOC2=C1C1=C2OCOC2=C(OC)C=C1CO KXMTXZACPVCDMH-UHFFFAOYSA-N 0.000 description 30
- 238000002360 preparation method Methods 0.000 description 29
- 238000004458 analytical method Methods 0.000 description 24
- 238000000034 method Methods 0.000 description 22
- 239000000543 intermediate Substances 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 239000002253 acid Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- HSFWRNGVRCDJHI-UHFFFAOYSA-N Acetylene Chemical compound C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 5
- 239000005977 Ethylene Substances 0.000 description 5
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 5
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 5
- 229910052786 argon Inorganic materials 0.000 description 5
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 5
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000012442 inert solvent Substances 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000007239 Wittig reaction Methods 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 4
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 4
- 229910052744 lithium Inorganic materials 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 4
- 150000003180 prostaglandins Chemical class 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- MLOSJPZSZWUDSK-UHFFFAOYSA-N 4-carboxybutyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CCCCC(=O)O)C1=CC=CC=C1 MLOSJPZSZWUDSK-UHFFFAOYSA-N 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 150000001602 bicycloalkyls Chemical class 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- FLHFTXCMKFVKRP-UHFFFAOYSA-N bromomethylcyclobutane Chemical compound BrCC1CCC1 FLHFTXCMKFVKRP-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- ZAJNGDIORYACQU-UHFFFAOYSA-N decan-2-one Chemical compound CCCCCCCCC(C)=O ZAJNGDIORYACQU-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229910003446 platinum oxide Inorganic materials 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- CMSYDJVRTHCWFP-UHFFFAOYSA-N triphenylphosphane;hydrobromide Chemical compound Br.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 CMSYDJVRTHCWFP-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- ZPGYUDWZVQOWNY-AATRIKPKSA-N (e)-hept-4-en-3-one Chemical compound CC\C=C\C(=O)CC ZPGYUDWZVQOWNY-AATRIKPKSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- SDTMFDGELKWGFT-UHFFFAOYSA-N 2-methylpropan-2-olate Chemical compound CC(C)(C)[O-] SDTMFDGELKWGFT-UHFFFAOYSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- BZKFMUIJRXWWQK-UHFFFAOYSA-N Cyclopentenone Chemical class O=C1CCC=C1 BZKFMUIJRXWWQK-UHFFFAOYSA-N 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 235000013418 Myrtus communis Nutrition 0.000 description 1
- 240000005125 Myrtus communis Species 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- NZHXEWZGTQSYJM-UHFFFAOYSA-N [bromo(diphenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(Br)C1=CC=CC=C1 NZHXEWZGTQSYJM-UHFFFAOYSA-N 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- WPOPOPFNZYPKAV-UHFFFAOYSA-N cyclobutylmethanol Chemical compound OCC1CCC1 WPOPOPFNZYPKAV-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229910000071 diazene Inorganic materials 0.000 description 1
- RAABOESOVLLHRU-UHFFFAOYSA-N diazene Chemical compound N=N RAABOESOVLLHRU-UHFFFAOYSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010931 ester hydrolysis Methods 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- ZPGYUDWZVQOWNY-UHFFFAOYSA-N hept-4-en-3-one Natural products CCC=CC(=O)CC ZPGYUDWZVQOWNY-UHFFFAOYSA-N 0.000 description 1
- 239000002035 hexane extract Substances 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 description 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000005603 pentanoic acids Chemical class 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- IPNPIHIZVLFAFP-UHFFFAOYSA-N phosphorus tribromide Chemical compound BrP(Br)Br IPNPIHIZVLFAFP-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000002731 stomach secretion inhibitor Substances 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/40—Halogenated unsaturated alcohols
- C07C33/44—Halogenated unsaturated alcohols containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
PATENT SPECIFICATION
( 11) 1 569 558 ( 21) Application No 40081/78 ( 62) Divided Out of No 1568781 ( 31) Convention Application No.
( 22) Filed 26 Jan 1977 ( 19) 657221 ( 32) Filed 11 Feb 1976 in ( 33) United States of America (US) ( 44) Complete Specification Published 18 Jun 1980 ( 51) INT CL 3 C 07 C 43/18 C 07 D 309/12 C 07 F 7/08 ( 52) Index at Acceptance C 2 C 1174 1200 1206 121 X 200 204 222 225 226 227 22 Y 237 304 305 30 Y 313 314 315 316 31 Y 339 351 355 Y 360 361 362 364 366 367 368 36 Y 37 X 386 401 40 Y 43 X 440 442 446 449 490 49 X 500 505 507 509 Y 562 56 Y 623 625 628 633 634 638 652 655 658 659 65 X 665 668 73 Y 776 778 779 AA BM BW HG UN WN WZ ( 54)1-IODO (OR CHLORO)-3-PROTECTED HYDROXY-W BICYCLOALKYL-1-ALKENES ( 71) We, MILES LABORATORIES INC a Corporation organised and existing under the laws of the State of Indiana United States of America, of 1127 Myrtle Street, Elkhart, Indiana 46514, United States of America, do hereby declare the invention, for which we pray that a patent may be granted to us the method by which it is to be performed, to be particularly described in and by the following statement.
This invention relates to 1-iodo (or bromo)-3-protected hydroxy-wbicycloalkyl-1alkenes.
In our Application No 3183/77 (Serial No 1568781) we describe and claim bicycloalkyl analogues or derivatives of prostaglandine A, E and F which are useful modifiers of smooth muscle activity These compounds have valuable pharmacological properties as platelet anti-aggregating agents and gastric anti-secretory agents The compounds are also valuable pharmacological agents for increasing femoral blood flow and decreasing blood pressure and heart rate.
These bicycloalkyl analogues of prostaglandins having the following structural formula; 1 L Q"ot,/^ _" (CI ') -B DJ (III) In Formula III:
g is O or an integer from 1 to 10:
D is a R-hydroxymethylene or S-hydroxymethylene radical:
J is a methylene, R-hydroxymethylene or S-hydroxymethylene:
K is a methylene or ethylene with the proviso that K is ethylene only when J is methylene or J and K together form a vinylene radical:
L is a carbonyl, R-hydroxymethylene or S-hydroxymethylene radical:
Q is an ethylene or Z-vinylene radical:
T is an alkoxycarbonyl having from 1 to 3 carbon atoms in the alkyl radical, carboxyl, or hydroxymethyl radical and B is a bicycloalkyl radical of the formula:
ttn On ior tn PS 222 1 569 558 11 I H where m and p are integers from 1 to 4; N is O or an integer from 1 to 4 with the proviso that n is not 1 when m and p are both 2 and p is not 1 when m and N are both 2: and the sum of m, N and p is greater than or equal to 3 and where the point of attachment of the alkylene chain 10 (CH 2)m bridge or bridgehead position and pharmacologically acceptable non-toxic salts thereof when T is a carboxy radical.
The numbering system and the stereochemistry nomenclature used are according to the I.U P A C definitive and tentative rules which designate the carboxylic acid side chain as the parent compound In formula III, serpentive line (-) denotes a covalent bond which 15 can be either in the alpha configuration (projecting below the plane of a reference carbon atom) or in the beta configuration (projecting above the plane of a reference carbon atom).
As used herein, cis or trans isomerism around double bonds respectively is designated by affixes Z (zusammen) and E (entgegen) Chirality around asymmetric carbon atoms is designated by affixes R (rectus) and S (sinister) 20 Compounds having formula III can be prepared via the 1,4-conjugate addition of organocopper reagents to cyclopentenones as reported by Sih, et al, (J Amer Chem.
SOC, & 7/8: 857,865 ( 1975) and references cited therein) The novel compounds of formula
III are prepared according to the reaction sequence depicted in Reaction Scheme A.
Reaction scheme A 25 X 2-/(clfzg}-B (y) OA (l) lithium (metallic or lower alk)yl lithium) (V) ( 2) Copper(r) Complex(vi) 30 01 ( 3) -T' (V 11) 0 C"" ') ' 35 K 4 '('I TI c Pg vr) ( 4) Iak acid at 20 ' to 45 'C.
o J r V Cl) T 40 4 (Sd) Wchal: cid \ (Sb) Na B Il 14/alcohol.
a.nd1t 4 O 45 \ % J,, -v \D(c 12) g \ J//t D ( c" z)g'-" (l Ia) ( 1 ff) B 50 - /, o 2.
J (c 2) g-1 < ( 1 llb) (Sc) Ester hydrolysis.
Wherein J' is methylene or = C Ho A where A is a hydroxy protective group as defined 55 below; K' is methylene or ethylene provided that K' is ethylene only when J' is methylene, T' is (C 1-3 alkoxy) carbonyl or CH 2 OA: T" is (C 1-3 alkoxy) carbonyl or hydroxy methyl and J" is methylene R-hydroxy methylene or S-hydroxymethylene.
The intermediates of formula IV wherein:
X is an iodine or bromine atom: 60 A is an acid-labile protecting group selected from 1-ethoxyethyl trimethylsilyl, tert-butyl-dimethylsilyl, 1-ethoxy-1-methylethyl triphenyl-methyl and tetrahydroxpyran-2yl radical:
g is O or an integer from 1 to 10; and B is a bicycloalkyl radical of the formula: 65 3 1 569 558 3 II c c 5 H where m and p are integers having a value of from 1 to 4; N is O or an integer having a value of from 1 to 4 provided that the sum of m, N and p is greater than or equal to 3 and the point of attachment of the alkylene chain (CH 2), to the bicycloalkyl radical is in the (CH 2)m 10 bridge or in the bridgehead position are novel and form the subject of the present invention.
These compounds can be prepared according to the reaction sequence depicted in Reaction Scheme B Examples of compounds of formula IV include: 1-iodo-3-( 1ethoxyethoxy)-3-(bicyclol 3 2 O lhept-3-yl) 1 E-propene; 1-iodo-3(ethoxyethoxy)-7 15 (bicyclol 3 2 1 loct 2-yl)-IE-heptene: 2-iodo-3-)2-ethoxyethoxy)-7-) bicyclol 4 4 O l dec-2-yl(l E-heptene and 1-iodo-3 p( 1-ethoxyethoxy)-4-(bicyclol 2 2 1 lhept 2-yl)l E-butene The synthesis of compound IV from the corresponding carboxylic acid I Va can be accomplished via the reaction sequence of Reaction Scheme B by well-known organic chemistry prodedures 20 REACTION SCHIEMIE B o HO/' (CH 2)o -n' (Ird') 1) SOC 12 or Oxalyl chloride or 25 similar reagent.
CI (CH 2) (r Bb) 2) Al C 13 or other similar Lewis 30 Al 13 3 acid; Acetylene; CCI 4 or C 12 C 12 or similar inert solvent.
O O cl -(CH,)a-1 (lye) 35 3) Nal, Na Br or L i Br or other similar soluble bromide or iodide salt; Acetone.
-0 40 xtf- -(C Hz)a-9-8 (n'd) 4) Na BH 4 or Li AIH 4 or other similar reducing agent/solvent.
(C ('e) 45 01 l S) Hydroxyl protecting agent such that A is acid labile 50 X, /(CH,) P 1 (Iv) OA In I Va-I Vb the carboxylic acid I Va is converted to the acid chlorice I Vb using an acid chloride forming reagent such as thionyl chloride, oxalyl chloride or phosphorus trichloride 55 as described in Fieser & Fieser, Reagents for Organic Synthesis 1: 1158, J Wiley & Sons Inc ( 1967) In I Vb >I Vc the acid chloride I Vb is reacted with acetylene in an inert solvent, such as carbon tetrachloride or methylene chloride, in the presence of a Lewis acid such as aluminium chloride or stannic chloride to produce the l 3-chlorovinyl ketone Vc as described in Chem Rev, 161 ( 1965) and Org Synth, IV: 186, J Wiley & sons Inc ( 1963) In I Vc 60 >I Vd, the 13-chlorovinyl ketone I Vc is converted into the corresponding 13-iodo or P 3-bromo-vinyl ketone I Vd, where X is an iodine or bromine atom, using a soluble salt, such as sodium iodide, sodium bromide or lithium bromide, in a polar inert solvent, such as acetone or acetonitrile as described in J Amer Chem Soc, 94: 7210 ( 1972) In I Vd-I Ve, compound I Vd is reduced to the corresponding 13-iodo or l 3-bromo-vinyl alcohol using a 65 A " 1 569 558 4 suitable reducing agent, such as sodium borohyxdride in an alcohol or lithium aluminium hydride in an ether as described in J Amer Chem Soc, 94 7210 ( 1972) In I Ve >IV, compound I Ve is protected with a suitable hydroxyl-protecting agent (A) by reaction with, for example, dihydropyran or ethyl vinyl ether in the presence of an acid catalyst such as p-toluene-sulphonic acid, 98 % sulphuric acid or phosphorus oxychloride; or a trialkylsilyl 5 chloride, such as trimethylsilyl chloride or t-butyldimethylsilyl chloride, or triphenylmethyl bromide in the presence of a basic catalyst such as triethylamine or imidazole Any hydroxyl protecting group that is removable under midly acid conditions and is stable alkyllithium and alkylcopper (I) reagents can also be suitably used, see J Org Chem 37: 1947 ( 1972).
Examples of the corresponding carboxylic acids having formula I Va include: bicyc 10 lol 3 2 Olheptane-3-carboxylic acid; 5;(bicyclol 3 2 lloct-2-yl)pentanoic acid; 5(bicyclol 4 4 O ldec-2-yl)pentanoic acid; and (bicyclol 2 2 1 lhept-2-yl) acetic acid The bicycloalkyl carboxylic acids of formula I Va are either commercially available or can be prepared by well-known techniques from commercially available materials For example, the compound cis-1,2-cyclobutanedicarboxylic anhydride is reduced with a suitable reagent, 15 such as lithium aluminium hydride, lithium borohydride, lithium tri-tbutoxyaluminium hydride or borane, to produce= cis-1,2-bis(hydroxymethyl)cyclobutane This latter compound is then substituted for trans-12-bis-(hydroxymethyl)cyclobutane in the procedure described in J Org Chem, 29 2914 ( 2964) for the preparation of trans(bicyclol 3 2 O lhept3-yl)carboxylic acid The product of this procedure is thus cis-(bicyclo-l 3 2)lhept-3 20 yl)carboxylic acid This latter compound is used in the reaction sequence depicted in Reaction Scheme B to produce 1-iodo-3-( 1-ethoxyethoxy)-3-(bicyclol 3 2 O lhept-3-yl)-IEpropene.
Other commercially available cis or trans isomers of 1 2dicarboxycycloalkyl: 1 2bis(hydroxy-methyl)cycloalkyl: or 1 2-bis(bromomethyl)cycloalkyl may be used in the 25 above procedure to produce compounds of structure I Va where g is O and B is /Àl 30 These latter compounds lead to prostaglandins of structure III in which g is O m is 3, N is O and p is 1 to 4.
5-(Bicyclol 3 2 1 loct-2-yl)pentanoic acid can be prepared by the following procedure The compound 2-oxobicyclol 3 2 11 octane is reacted with a suitable base, such as sodium hydride, potassium hydride, lithium hydride, lithium diisopropylamide, or lithium 35 t-butoxide, and ( 4-carboxybutyl)triphenyl phosphonium bromide in an inert solvent such as dimethyl sulphoxide, benzene, diethyl ether t-butanol or mixtures thereof via a Wittig reaction (Tet Let, 4: 311 l 1970 l) to produce the intermediate compounds 5(bicyclol 3 2 1 l-oct-2-ylidene)pentanoic acid This latter compound is catalytically reduced in a suitable solvent such as ethanol or other alcohol or an organic acid in the presence of a 40 hydrogenation catalyst such as platinum oxide Pd on carbon Ru O,, or RaNi and a reducing agent such as hydrogen or diimide to produce 5-(bicyclo-l 3 21 loct-2-yl)pentanoic acid This latter compound is used in the reaction sequence depicted in Reaction Scheme B to produce 1-iodo-3-( 1-ethoxyethoxy)-7-(bicyclol 3 2 1 loct-2-yl)-1 Eheptene.
Other commercially available or easily prepared oxobicvclolm n plalkanes can be used in 45 place of 2-oxobicyclol 3 2 1 loctane in the Wittig reaction to yield a variety of 5(bicyclolm n plalkylidene)pentanoic acids which can then be used in the synthesis of a variety of prostaglandins with Structure III For example cis or trans (bicyclol 4 4 O ldecan1-one) may be used in the above Wittig reaction followed by the reduction to produce 1-iodo-3-( 1-ethoxyethoxy)-7-(bicyclol 4 4 0 ldec-1-yl)-l E-heptene 50 Easily prepared (co-carboxyalkyl)triphenyl-phosphonium bromide reagents may be used in place of( 4-carboxybutyl)triphenylphosphonium bromide in the Wittig reaction to yield o-(bicyclolm n p lalkylidene) alkanoic acids which can then be used in the synthesis of prostaglandins with structure III The (o-carboxy-alkyl) triphenylphosphonium bromide reagents are most easily prepared by reacting triphenylphosphine with an o-bromalkanoic 55 acid in an inert solvent such as benzene, acetonitrile or diethyl ether, usually at an elevated temperature such as solvent reflux The products are usually isolated as crystalline salts which separate from the reaction mixture upon cooling The following Examples further illustrate the present invention.
60 Example 1
This example illustrates a typical preparation of the compound 1-iodo-3 RS-( 1ethoxyethoxy)-7-(bicyclol 3 2 1 loct-2-yl)-1-E-heptene.
A Preparation of 5-(bicvclol 3 2 1 loct-2-vl-idente)pentanoic acid.
A mixture of 3 92 g ( 93 mmol) of sodium hydride ( 57 % oil dispersion) and 30 ml of dry 65 A 1 569 558 5 dimethyl sulphoxide was heated at 70-80 C under nitrogen until gas evolution ceased ( 2 5 hours) The mixture was cooled, and 19 7 g ( 44 3 mmol) of 4-(carboxybutyl) triphenylphosphonium bromide (Aldrich # 15,794-5)was added, followed by 20 ml of dimethyl sulphoxide The resulting deep red mixture was stirred for 45 minutes at room temperature under nitrogen before a solution of 5 0 g ( 50 2 mmol) of bicyclol 3 2 1 l-octan 5 2-one (Aldrich # 11,903-2) in 20 ml of dimethyl sulphoxide was added dropwise over 1 75 hours The resulting mixture was stirred for 16 hours at room temperature before it was quenched by the addition of 125 ml of water The resulting solution was extracted with three 250 ml portions of diethyl ether/ethyl acetate-1:1 (V/V) to remove neutral by-products The remaining aqueous phase was acidified by the addition of 15 ml of 10 concentrated hydrochloric acid and extracted with three 250 ml portions of diethyl ether-hexane-1:1 (V/V) These combined acidic ether-hexane extracts were dried (Mg SO 4), and evaporated in vacuo to yield 6 0 g of crude 5-(bicyclol 3 2 1 l-oct-1ylidene)pentanoic acid as an oil This oil was purified by chromatography on silica gel 60 (elution with CHC 13 containing 0 5 % formic acid) to yield 4 1 g ( 49 %) of pure material as a colourless oil 15 Analysis IR:)CHC 13 max 5 87 lt 3 41 lt and 2 86 to 4 17 lx (broad) 20 NMR(DC 13) 6 3 0 broad, 1 H 6 4 9 broad triplet, 1 H 25 B Preparation of 5-(bicvclol 3 2 1 loct-2-yl)-pentanoic acid.
A solution of 3 4 g ( 16 3 mmol) of 5-(bicyclo-l 3 2 1 loct-2-ylidene) pentanoic acid in 100 ml of absolute ethanol was hydrogenated at 50 psi over 300 mg of platinum oxide in a Parr apparatus After 1 5 hours hydrogen uptake became slow After 4 hours the system was flushed with nitrogen, and the catalvst was removed by filtration through diatomaceous 30 earth filter aid ("'Celite") lRegistered Trade Markl The filtrate was evaporated in vacuo to yield 3 25 g ( 96 % of quite pure 5-(bicyclol 3 2 1 loct-2-yl)pentanoic acid as a colourless oil.
Analysis IR: x CHC 13 5 85 t, 3 41 t and 2 86 to 4 17 u 35 max (broad) NMR(CD C 13): 6 11 6, broad singlet, 1 H.
C Preparation of 2-Chloro-7-(bicvclol 3 2 1 l-oct-2-vl(-1 E-hepten-3-one.
A solution of 7 2 g ( 32 mmol) of 5-(bicyclo-l 3 2 1 loct-2-yl)pentanoic acid in 20 ml of 40 thionyl chloride was left overnight at room temperature under nitrogen The excess thionyl chloride and by-products were removed by evaporation in vacuo The resulting acid chloride ( 7 8 g) was used in the following procedure A 65 ml portion of carbon tetrachloride in a flask fitted with a gas addition tube, dropping funnel, and mechanical stirrer was saturated at O with acetylene which had been passed through an activated 45 aluminium oxide trap followed by two concentrated sulphuric acid traps A 5 2 g ( 40 mmol) portion of anhydrous aluminium chloride was added as acetylene was continuously bubbled through the mixture The above acid chloride was added dropwise followed by a small amount of carbon tetrachloride rinse Acetylene was bubbled through the resulting mixture for an additional 4 hours The mixture was then quenched with a 50 ml of crushed ice and 75 50 ml of brine The layers which resulted were separated The aqueous layer was extracted with three 75 ml portions of diethvl ether The combined ethereal extracts were washed with 10 % aqueous HC 1 three times, saturated aqueous sodium bicarbonate three times, dried (Mg SO 4), and evaporated in vacuo to yield 8 8 g of residue which was chromatographed on silica gel (benzene elution) to give 3 2 g ( 37 %) of pure 1-chloro-7 55 (bicyclol 3 2 1 loct-2-yl)-1 E-hepten-3-one:
Analysis NMR(CDC 13): 6 2 5 broad t J= 6 5 Hz 2 H 6 6 48 doublet, J= 13 5 Hz, 1 H 6 7 28 doublet J= 13 5 Hz, 1 H 60 D Preparation of 1-iodo-7-(bicyclo/3 2 1 J-oct-2-yl)-l E-hepten-3-one.
A solution of 3 2 g ( 13 mmol) of 1-chloro-7-(bicyclol 3 2 1 loct-2-yl)-l E 4-hepten-3-one and 7 5 g ( 50 mmol) of sodium iodide in 25 ml of dry acetone(distilled from potassium carbonate) was refluxed for 18 hours under nitrogen The solvent was removed in vacuo,, 65 "o 1 569 558 6 and the residue was taken up in 50 ml of water and then extracted three times with 30 ml portions of diethyl ether The combined ethereal extracts were washed with aqueous sodium thiosulphate, dried (Mg SO 4) and evaporated in vacuo to yield 3 8 g ( 88 % of 1-iodo-7-(bicyclol 3 2 1 loct-2-yl)-l E-hepten-3 one.
5 Analysis NMR(CDC 13): 6 2 5, broad t, J = 6 7 Hz, 2 H 6 7 08, doublet, J= 15 Hz, 1 H 6 7 78, doublet, J= 15 Hz, 1 H.
10 E Preparation of 1-iodo-7-(bicyclol 3 2 11-oct 2 vl)-l E-hepten-3 RS-ol.
To a solution of 3 8 g ( 10 9 mmol) of 1-iodo-7-(bicyclol 3 2 1 loct-2-yl) -l E-hepten-3-one in 50 ml of absolute ethanol under argon at o was added a slurry of 1 6 g ( 44 mmol) of sodium borohydride in 50 ml of ethanol The resulting mixture was stirred for 1 hour, and the solvent was removed in vacuo The residue was taken up in 100 ml of water and 15 extracted with three 100 ml portions of diethyl ether the combined extracts were dried (Mg SO 4) and evaporated in vacuo to yield 4 0 g ( 100 %) of 1-iodo-7(bicyclol 3 2 2 loct-2yl)-1 l E-hepten-3 rs-ol; Analysis IR: CHC 13 10 65 p 3 43 l, 2 91 and 2 79 20 max NMR(CDC 13): 6 4 1, broad, 1 H 6 6 15 to 6 75, complex 2 H.
F Preparation of 1-iodo-3 RS-( 1-ethoxyethoxv)-7-(bicvclol 3 2 lloct-2-vl) -l E-heptene 25 To a solution of 4 0 g ( 11 mmol) of 1-iodo-7-(bicyclol 3/8 s/4 /slOCT /4-YL(-l/s E-hepten3-ol in 15 ml of ethyl vinyl ether was added two drops of phosphorous oxychloride After standing for 18 hours at room temperature the resulting solution was washed with saturated aqueous sodium bicarbonate The wash solution was back extracted twice with diethyl ether The combined ethereal extracts were washed once with saturated aqueous sodium 30 chloride, dried (Mg SO 4) and evaporated to yield a yellow oil This yellow oil was chromatographed on silica gel (benzene elution) to yield 1 6 g of 1-uiodo3 RS-( 1ethoxyethoxy)-7-)bicyclo-l 3 2 1 loct-2-yl)-l E-heptene and 1 0 g of the unprotected starting material which was recycled The spectrum of pure product was:
Analysis NMR(CDC 13): 63 24 to 3 73, multiplet 2 H 35 6 3 97, broad, 1 H 6 4 67, quartet J= 5 3 Hz 1 H 6 6 08 to 6 65 multiplets 2 H.
Example 2 40
This example illustrates a typical preparation of 1-iodo-3 RS-( 1ethoxyethoxy)-7(bicyclol 4 4 10 ldec-2-yl)-l E-heptene.
A Preparation of 5-(bicyclol 4 4 O ldec-2-vlidene)pentanoic acid.
Repeating in a similar manner the procedure of Example 1 above but replacing bicyclol 4 4 O ldec-2-ylidene)pentanoic acid 45 Repeating in a similar manner the procedure of Example 1 above replacing bicyclol 3 2 1 loctan-2-one with bicyclol 4 4 O decan-2-one ( 2-decalone Aldrich # 15 506-3) yields the intermediate 5-(bicyclol 4 4 0 -dec-2-ylidene)pentanoic acid.
Analysis NMR(CDC 13): 6 5 0 triplet, J= 6 5 Hz 1 H 6 10 4 broad singlet 1 H 50 B Preparation of 5-(bicyclol 4 4 O ldec-2-vl)-pentanoic acid.
Repeating in a similar manner the procedure of Example l B above but replacing 5-(bicyclol 3 2 1 loct-2-ylidene)pentanoic acid with 5-bicyclol 4 4 O ldec-2-ylidene)pentanoic acid yields the intermediate 5-(bicyclol 4 4 O ldec-2-yl)pentanoic acid 55 Analysis NMR(CDC 13: 6 10 0 broad singlet 1 H C Preparation of 1-chloro-7-(bicvclo/4 4 O l-dec-2-yl)-i E-hepten-3-one.
Repeating in a similar manner the procedure of Example 1 C above, but replacing 5-(bicyclol 3 2 1 l-oct-2-yl)pentanoic acid with 5-(bicyclol 4 4 O ldec-2yl)-pentanoic acid yields the intermediate 1-chlor-7-(bicyclol 4 4 O ldec-2-yl)-l E-hepten-3one 60 Analysis NMR(CDC 13): 6 2 5 broad triplet J= 6 5 Hz 2 H 6 6 4, doublet, J= 13 Hz, 1 H 6 7 3, doublet J= 13 Hz 1 H.
D Preparation of l-iodo-7-(bicvclo/4 4 O l-dec-2-yl)-IE-hepten-3-one 65 f.
r 1 569 558 / Repeating in a similar manner the procedure of Example y above, but replacing 1-chloro-7-l 3 2 1 l-oct-2-yl)-1 E-epten-3-one with 1-chloro-7-(bicyclo-l 4 4 O ldec-2-yl)-1 Ehepten-3-one yields the intermediate 1-iodo-7-(bicyclol 4 4 O ldec-2-yl)l E-hepten-3-one.
Analysis NMR(CDC 13): 5 2 5, broad triplet, J= 6 5 Hz, 2 H 6 7 1, doublet, J= 14 Hz, 1 H 5 6 7 8, doublet, J= 14 Hz, 1 H E Preparation of 1-iodo-7-(bicyclo(bicyclol 4 4 Oldec-2-yl)-1 E-hepten-3 RS-ol.
Repeating in a similar manner the procedure of Example 1 E above, but replacing 1-iodo-7-(bicyclo-l 3 2 1 loct-2-yl)-l E-hepten-3-one with 1-iodo-7(bicyclo-l 4 4 O ldec-2-yl)le-hepten-3-one yields the intermediate 1-iodo-7-(bicyclol 4 4 O ldec-2yl)l E-hepten-3 RS 10 ol.
Analysis NMR(CDC 13): 6 4 17, multiplet, 1 H 6 6 0 to 7 0 multiplet, 2 H.
F Preparation of 1 -iodo-3 RS-( 1-ethoxy-ethoxy) -7-(bicyclol 4 4 Odec-2yl) -1 E-heptene.
Repeating in a similar manner the procedure of Example i F above, but replacing 15 1-iodo-7-(bicyclo-l 3 2 lloct-2-yl)-l E-hepten-3 RS-ol with 1-iodo-7 (bicyclol 4 4 O ldec-3-yl)1 E-hepten-3 RS-ol yields the intermediate 1-iodo-3 RS-( 1-ethoxyethoxy)7(bicyclol 4 4 O ldec-2-yl) l E-heptene.
Analysis NMR(CDC 13): 6 3 5 to 4 2, multiplet, 3 H 6 4 8, multiplet, 1 H 20 6 6 0 to 7 0 multiplet, 2 H.
Example 3
This example illustrates a typical preparation of 1-iodo-3 RS-( 1ethoxyethoxy)-3(bicyclol 3 2 O l-hept-3-yl)-l E-propene 25 A Preparation of cis-1,2-bis-(hvdroxymethyl)cvclobultane.
A solution of 50 0 g ( 0 40 mmol) of cis-1,2-cyclobutanedicarboxylic anhydride (Aldrich # 14,543-2) in 50 ml of diethyl ether and 75 ml of THF was added in small portions to a O C slurry of 21 0 g of lithium aluminium hydride in 200 ml of diethyl ether in a 500 ml three-necked roundbottomed flask equipped with a reflux condenser, mechanical stirrer, 30 addition funnel and argon inlet The reaction mixture was warmed to 50 C and stirred for 1 hour Ethyl acetate ( 31 0 ml) was added dropwise followed by 21 0 ml water, 21 0 ml 15 % w/v aqueous sodium hydroxide and 40 ml of water The reaction mixture was stirred for 18 hours at 25 C then filtered The filtrate was washed with brine and vacuum distilled to afford 21 5 g of cis-1,2-bis-(hydroxymethyl)cyclobutane as a clear oil, b p 94-97 (vacuum 35 pump).
Analysis IR:)CHC 13 2 78 lt, 3 0 It (broad), 5 9 t.
max NMR(CDC 13): 6 10-2 30, multiplet, 4 H, CH 2-CH 2 40 6 2 65 multiplet, 2 H CH-CH 6 3 60 multiplet, 4 H CH 2 OH 6 4 65 broad t 2 H, OH B Preparation of cis-1,2-bix(bronmomnethvl)-cvclobutane.
To 44 g of phosphorous tribromide (-10 C was added dropwise 10 7 g of distilled 45 cis-1 2-bis-(hydroxymethyl)cyclobutane over a 1 hour period The reacti) on mixture was warmed to 25 C and stirred for 2 hours, then heated to 80-85 C for 18 hours The reaction mixture was cooled in ice and cold water added The layers were separated and the aqueous layer was extracted with methylene chloride The organic extracts were combined, washed with 5 % w/v aqueous sodium carbonate and water, then distilled to yield 13 8 g of 50 cis-12,2-bis(bromomethyl)cyclobutane as a purple oil, b p 86 C (vacuum pump).
Analysis IR: CHC 13 3 4 u 7 O u, 8 1 p (no OH signal max observed NMR(CDC 13): 6 1 3 -2 5 multiplet, 4 HCH 2-CH 2 55 6 2 8 multiplet, 2 H CH-CH 6 3 5, multiplet, 2 H CH,-Br.
C Preparation of 3, 3-bix(ethoxycarbonvl)-bicyclol 3 2 O lheptane.
In a 250 ml (round bottomed flask equipped with mechanical stirring reflux condenser, addition funnel and argon inlet was placed 20 2 g of cis-12-bis(bromomethyl)cyclobutane, 60 12.4 ml diethyl malonate and 72 ml of dry-t-butanol The reaction mixture was refluxed and a solution of 19 9 g of potassium t-butoxide in 123 ml of t-butanol was added over 6 0 hour The reaction mixture was refluxed for 15 hours The reaction mixture was cooled by external application of an ice-water bath and an equal volume of water added The mixture was extracted with diethyl ether The ethereal extracts were washed with 3 N hydrochloric 65 1 569 558 acid abd 5 % w/v aqueous sodium bicarbonate, then dried (Mg SO 4), filtered and distilled in vacuo to yield 10 3 g of 3,3-bis-(ethoxycarbonul)bicyclol 3 2 10 lheptane as a clear oil b p.
100-105 C (vacuum pump).
Analysis IR: k CHC 113 5 85 t 5 max NMR(CDC 13) 6 1 22, pair of t, J= 7 O Hz broad, CH 2 CH 3 D 6 4 37 quartet, 4 H, CH 2 CH 3.
D Preparation of bicyclol 3 2 O lheptane-3,3-dicarboxvlic acid 10 A solution of 10 3 g of 3,3-bis(ethoxycarbonyl)-bicyclol 3 2 O lheptane in 68 ml of 16 % w/v potassium hydroxide in 1:1 v/v methanol-water was refluxed for 16 hours under argon The solvents were removed in vacuo and the residue dissolved in a minimum amount of water.
The solution was acidified with concentrated hydrochloric acid and the precipitated acid isolated by vacuum filtration to yield 6 9 g of bicyclol 3 2 O lheptane-3, 3-dicarboxylic acid as 15 a white solid, m p 161-170 .
Analysis NMR(DMSO-d 6): 6 7 65, broad singlet, 2 H, CO 2 H.
E.Preparation of cis-(bicyclol 3 2 Olhept-3-vl)-carboxylic acid.
Bicyclol 3 2 O lheptane-3,3-dicarboxylic acid ( 6 90 g) was heated at 190 C under argon for 1 hour to afford 4 75 g of cis-(bicyclol 3 2 O lhept-3-yl)-carboxylic acid as a brown oily solid 20 Analysis NMR(CDC 13): 6 10 18, broad singlet.
1 H, CO 2 H IR(CHC 13: 2 75-4 4 R (broad), 5 85 , 6 40 l.
F preparation of 1-chloro-3-(bicyclol 3 2 O l-hept-3-vl)-l E-propen-3-one.
Repeating in a similar manner the procedure of Example 1 C above, but replacing 25 5-(bicyclol 3 2 1 loct-2-yl)pentanoic acid with bicyclol 3 2 O lheptane-3carboxylic acid yields the intermediate 1-chloro-3-(bicyclol 3 2 0 lhept-3-yl)-l E-propen-3-one.
Analysis NMR(CDC 13): b 6 66 doublet J= 14 Hz 1 H 6 7 36 doublet, J= 14 Hz 1 H G Preparation of 1-iodo-3-(bicyclol 3 2 o I-hept-3-yl)-l E-propen-3-one 30 Repeating in a similar manner the procedure of Example 1 D above, but replacing 1-chloro-7-(bicyclo-l 3 2 1 loct-2-yl)-l E-hepten-3-one with 1-chloro-3(bicyclo-l 3 2 O lhept-3yl-l E-propen-3-one to yield the intermediate 1-iodo-3-(bicyclol 3 2 O lhept-3-yl)-i E-propen3-one.
Analysis NMR(CDC 13): 6 7 27 doublet J= 15 Hz 1 H 35 6 7 99, doublet, J= 15 Hz 1 H H Preparation of 1-iodo-3 (bicyclol 3 2 01-hept-3-yl)-6-propen-3 RS-ol.
Repeating in a similar manner the procedure of Example 1 E above, but replacing 1-iodo-7-(bicyclol 3 2 1 l-oct-2-yl)-l E-hepten-3-one with 1-iodo-3(bicyclo-l 3 2 O lhept-3-yl)1 E-propen-3-one yields the intermediate 1-iodo-3-(bicyclol 3 2 O lhept-3yl)-l E-propen 40 3 RS-ol.
Analysis NMR(CDC 13): 6 4 2, multiplet 1 H 6 6 26, doublet J= 15 Hz 1 H 6 6 62 doublet of doublets, Jx 15 and 6 Hz 1 H 45 I Preparation of 1 -iodo-3 RS-( 1-ethoxyethoxy) -3-(bicvclol 3 2 Ohept-3yl)-l E-propene.
Repeating in a similar manner the procedure of Example 1 F above, but replacing 1-iodo-7-(bicyclo-l 3 2 1 loct-3-yl)-l E-hepten-3 RS-ol with 1-iodo-3(bicyclo-l 3 2 O lhept-3yl)-l E-propen-3 RS-ol yields the intermediate 1-iodo-3 RS-( 1ethoxyethoxy)-3-(bicyclol 3 2 O lhept-3-yl)-l E-propen 50 Analysis 6 3 5 to 4 2, multiplet, 3 H 6 4 8, multiplet, 1 H 6 6 0 to 7 0, multiplet, 2 H.
Example 4 55
This Example illustrates a typical preparation of 1-iodo-3 RS-( 1ethoxyethoxy)-4(bicyclol 2 2 1 lhept-2-yl)-l E-butene.
A Preparation of 1-chloro-4-(bicvclo-/2 2 1 lhept-2-vl)-JE-buten-3-one.
Repeating in a similar manner the procedure of Example 1 C above, but replacing 5-(bicyclo-l 3 2 1 loct-2-yl)pentanoic acid with (bicyclol 2 2 1 l-hept-2yl)acetic acid (Aldrich 60 # 12,726-4) yields the intermediate 1-chloro-4-(bicyclol 3 2 1 lhept-2-yl) -l Ebuten-3-one.
Repeating in a similar manner the procedure of Example 1 D above, but replacing 1-chloro-7-(bicyclol 3 2 1 loct-2-yl)-hept-2-yl)-1 l E-propen-3-one with 1-chloro-4-(bicvclol 2 2 1 lhept-2-yl)-l Ebuten-3-one yields the intermediate 1-iodo4(bicyclol 2 2 1 lhept-2-yl)-l E-buten-3-one 65 1 569 558 Analysis NMR(CDC 13): 6 7 20, doublet, J= 15 Hz, 1 H 1 6 7 85, doublet, J= 15 Hz, 1 H, C Preparation of 1-iodo-4-(bicvclol 2 2 1 l-hept-2-vl) -1 E-buten-3 RS-ol.
Repeating in a similar manner the procedure of Example 1 E above, but replacing 1-iodo-7-(bicyclo-l 3 2 1 loct-2-yl-l E-hepten-3-one with 1-iodo-4(bicyclo-l 2,2, lhept-2-yl) 5 1 E-propen-3-one yields the intermediate 1-iodo-4-(bicyclol 2 2 llhept-2yl) 11 E-propen3 RS-ol.
Analysis NMR(CDC 13): 6 5 04, multiplet, 1 H 6 6 1 to 6 8, multiplet, 2 H.
D Preparation of 1-iodo-3 RS-( 1-ethoxv-ethoxy)-4-(bicyclol 2 2 1 lhept-2yl)-l Ebutene 10 Repeating in a similar manner the procedure of Example i F above, but replacing 1-iodo-7-(bicyclol 3 2 1 l-oct-2-yl)-l E-hepten-3 RS-ol with 1-iodo-4(bicyclol 2 2 1 l-hept-2yl)-l E-propen-3 RS-ol yields the intermediate 1-iodo-3 RS-( 1aethoxyethoxy)-4(bicyclol 2 2 1 lhept-2-yl)-l E-butene.
Analysis NMR(CDC 13): 6 3 5, multiplet, 3 H 15 6 4 7, multiplet, 1 H 6 6 1 to 6 6 multiplet, 2 H.
Claims (1)
- WHAT WE CLAIM IS:1 A compound having the formula:20 X (CH 2)g-B OA wherein: 25 X is an iodine or bromine atom:A is an acid-labile protecting group which is 1-ethoxyethyl, trimethylsilyl, tert-butyldimethyl-silyl, 1-ethoxy-1-methylethyl tetrahydropyran-2-yl or triphenylmethyl radical:g is O or an integer from 1 to 10, and B is a bicycloalkyl radical of the formula: 30 IT C ( C T 2) (Ctl N ( 2)p c 35 It where m and p are independently integers from 1 to 4: N is O or an integer from 1 to 4 such that the sum of m, N and p is greater than or equal to 3 and the point of attachment of the alkylene chain (CH 2)g to the bicyclo-alkyl radical is in the (CH,)m bridge or in the 40 bridgehead position.2 A compound according to claim 1, wherein m has a value of 3 or 4 and N has a value of 0 or 1.3 A compound according to claim 1 wherein g has a value of from 0 to 4; m has a value of 3 or 4 N has a value of or 1; andvalueoforand as a value of from 2 to 4 45 4 1-Iodo-3 RS-( 1-ethoxyethoxy)-7-(bicyclo-l 3 2 1 oct-2-yl)-l E-heptene.1-Iodo-3 RS-( 1-ethoxvethoxy)-7-(bicyclo 4 4 0 dec-2-vll-l E-heptene.6 1-Iodo-3-RS-( 1-ethoxyethoxv)-3-(bicyclo-l 3 2 lhept-3-yl)-1 E-propene.7 1-Iodo-3 RS-( 1-ethoxyethoxy)-4-(bicyclol 2 2 1 lhept-2-yl)-1 E-butene.50 J.A KEMP & Co, Chartered Patent Agents, 14, South Square.Grav's Inn.LONDON WC 1 R 5 EU 55 Printed for Her Majest's Stationery Office, by Croydon Printing Company Limited Croydon, Surrey, 1980.Published b 5 The Patent Office 25 Southampton Buildings London WC 2 A l AY,from "hich copies may be obtained.f
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/657,221 US4074063A (en) | 1976-02-11 | 1976-02-11 | Bicycloalkyl derivatives of prostaglandins |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1569558A true GB1569558A (en) | 1980-06-18 |
Family
ID=24636314
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB40079/78A Expired GB1569556A (en) | 1976-02-11 | 1977-01-26 | 1-protected hydroxy-7-(3r-protected hydroxy-5-oxocyclopent-1-enyl)heptanes and hept-5z-enes |
GB40081/78A Expired GB1569558A (en) | 1976-02-11 | 1977-01-26 | 1-iodo (or chloro)-3-3-protected hydroxy-w-bicycloalkyl-1-alkenes |
GB3183/77A Expired GB1568781A (en) | 1976-02-11 | 1977-01-26 | Bicycloalkyl derivatives of prostaglandins |
GB40080/78A Expired GB1569557A (en) | 1976-02-11 | 1977-01-26 | Methyl 7-(6 1 oxocyclohex-1-enyl)-hept-5z-enoate |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB40079/78A Expired GB1569556A (en) | 1976-02-11 | 1977-01-26 | 1-protected hydroxy-7-(3r-protected hydroxy-5-oxocyclopent-1-enyl)heptanes and hept-5z-enes |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3183/77A Expired GB1568781A (en) | 1976-02-11 | 1977-01-26 | Bicycloalkyl derivatives of prostaglandins |
GB40080/78A Expired GB1569557A (en) | 1976-02-11 | 1977-01-26 | Methyl 7-(6 1 oxocyclohex-1-enyl)-hept-5z-enoate |
Country Status (17)
Country | Link |
---|---|
US (5) | US4074063A (en) |
JP (1) | JPS5297954A (en) |
BE (1) | BE851303A (en) |
CA (1) | CA1105040A (en) |
CH (1) | CH630353A5 (en) |
DE (1) | DE2705613C3 (en) |
DK (1) | DK56877A (en) |
FR (2) | FR2354319A1 (en) |
GB (4) | GB1569556A (en) |
IE (1) | IE45085B1 (en) |
IL (1) | IL51294A (en) |
NO (1) | NO144146C (en) |
NZ (1) | NZ183111A (en) |
PH (1) | PH18811A (en) |
PT (1) | PT66138A (en) |
SE (1) | SE431450B (en) |
ZA (1) | ZA77797B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4444691A (en) * | 1972-07-24 | 1984-04-24 | American Cyanamid Company | 11-Cyano-prostaglandins of the F-series |
US4074063A (en) * | 1976-02-11 | 1978-02-14 | Miles Laboratories, Inc. | Bicycloalkyl derivatives of prostaglandins |
US4206151A (en) * | 1978-12-21 | 1980-06-03 | American Cyanamid Company | 15-Deoxy-16-hydroxy-16-vinyl or cyclopropyl prostan-1-ols of the E, A and F series |
US4267395A (en) * | 1979-07-05 | 1981-05-12 | The Upjohn Company | 2-Decarboxy-2-hydroxymethyl-19-hydroxy-19-methyl-6A-carba-PGI2 compounds |
US5631370A (en) * | 1988-01-20 | 1997-05-20 | Regents Of The University Of Minnesota | Optically-active isomers of dideoxycarbocyclic nucleosides |
US5175292A (en) * | 1988-01-20 | 1992-12-29 | Regents Of The University Of Minnesota | Intermediates for the preparation of dideoxycarbocyclic nucleosides |
US20090110638A1 (en) * | 2007-10-24 | 2009-04-30 | California Institute Of Technology | Methods using the grueneberg ganglion chemosensory system |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3591613A (en) * | 1969-01-07 | 1971-07-06 | Ayerst Mckenna & Harrison | Cyclopentanedicarboxylic acid derivatives |
GB1398072A (en) * | 1971-06-14 | 1975-06-18 | May & Baker Ltd | Cyclopentane derivatives |
US3853951A (en) * | 1971-07-14 | 1974-12-10 | American Cyanamid Co | Preparation of 9-oxo-13-trans-prostenoic acid esters by alanate addition to cyclopentenone |
US3803244A (en) * | 1972-01-03 | 1974-04-09 | Monsanto Co | Acetals of 2-alkyl-3-norbornyl propanals |
IL43571A (en) * | 1972-11-08 | 1977-08-31 | Pfizer | Omega-pentanorprostaglandins and their preparation |
US3886185A (en) * | 1973-04-16 | 1975-05-27 | Syntex Inc | Novel prostaglandin intermediates and process for the production thereof |
JPS50151843A (en) * | 1974-05-02 | 1975-12-06 | ||
GB1476661A (en) * | 1974-05-13 | 1977-06-16 | American Cyanamid Co | Prostaglandins |
US4074063A (en) * | 1976-02-11 | 1978-02-14 | Miles Laboratories, Inc. | Bicycloalkyl derivatives of prostaglandins |
-
1976
- 1976-02-11 US US05/657,221 patent/US4074063A/en not_active Expired - Lifetime
-
1977
- 1977-01-17 IE IE84/77A patent/IE45085B1/en not_active IP Right Cessation
- 1977-01-18 NZ NZ183111A patent/NZ183111A/en unknown
- 1977-01-19 IL IL51294A patent/IL51294A/en unknown
- 1977-01-20 CA CA270,088A patent/CA1105040A/en not_active Expired
- 1977-01-26 GB GB40079/78A patent/GB1569556A/en not_active Expired
- 1977-01-26 GB GB40081/78A patent/GB1569558A/en not_active Expired
- 1977-01-26 GB GB3183/77A patent/GB1568781A/en not_active Expired
- 1977-01-26 GB GB40080/78A patent/GB1569557A/en not_active Expired
- 1977-02-02 PT PT66138A patent/PT66138A/en unknown
- 1977-02-09 CH CH157077A patent/CH630353A5/en not_active IP Right Cessation
- 1977-02-09 JP JP1257477A patent/JPS5297954A/en active Pending
- 1977-02-10 SE SE7701517A patent/SE431450B/en not_active IP Right Cessation
- 1977-02-10 FR FR7703807A patent/FR2354319A1/en active Granted
- 1977-02-10 BE BE174829A patent/BE851303A/en not_active IP Right Cessation
- 1977-02-10 NO NO770438A patent/NO144146C/en unknown
- 1977-02-10 DE DE2705613A patent/DE2705613C3/en not_active Expired
- 1977-02-10 DK DK56877A patent/DK56877A/en not_active Application Discontinuation
- 1977-02-11 ZA ZA770797A patent/ZA77797B/en unknown
- 1977-07-21 US US05/817,622 patent/US4115438A/en not_active Expired - Lifetime
- 1977-07-22 US US05/818,057 patent/US4115453A/en not_active Expired - Lifetime
- 1977-07-22 US US05/818,056 patent/US4108892A/en not_active Expired - Lifetime
- 1977-07-25 US US05/818,995 patent/US4149017A/en not_active Expired - Lifetime
- 1977-11-03 FR FR7733011A patent/FR2366250A1/en active Granted
-
1981
- 1981-08-18 PH PH26066A patent/PH18811A/en unknown
Also Published As
Publication number | Publication date |
---|---|
SE7701517L (en) | 1977-08-12 |
BE851303A (en) | 1977-05-31 |
SE431450B (en) | 1984-02-06 |
US4074063A (en) | 1978-02-14 |
GB1568781A (en) | 1980-06-04 |
DE2705613C3 (en) | 1979-06-28 |
NZ183111A (en) | 1978-11-13 |
NO770438L (en) | 1977-08-12 |
CH630353A5 (en) | 1982-06-15 |
FR2354319A1 (en) | 1978-01-06 |
US4149017A (en) | 1979-04-10 |
IL51294A (en) | 1981-05-20 |
JPS5297954A (en) | 1977-08-17 |
IE45085B1 (en) | 1982-06-16 |
GB1569556A (en) | 1980-06-18 |
US4108892A (en) | 1978-08-22 |
NO144146C (en) | 1981-07-01 |
PT66138A (en) | 1977-03-01 |
DE2705613B2 (en) | 1978-11-09 |
DK56877A (en) | 1977-08-12 |
DE2705613A1 (en) | 1977-08-18 |
FR2366250A1 (en) | 1978-04-28 |
NO144146B (en) | 1981-03-23 |
FR2354319B1 (en) | 1980-07-18 |
CA1105040A (en) | 1981-07-14 |
IE45085L (en) | 1977-08-11 |
US4115453A (en) | 1978-09-19 |
ZA77797B (en) | 1977-12-28 |
PH18811A (en) | 1985-09-27 |
GB1569557A (en) | 1980-06-18 |
FR2366250B1 (en) | 1982-12-17 |
US4115438A (en) | 1978-09-19 |
IL51294A0 (en) | 1977-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bernady et al. | Prostaglandins and congeners. 20. Synthesis of prostaglandins via conjugate addition of lithium trans-1-alkenyltrialkylalanate reagents. A novel reagent for conjugate 1, 4-additions | |
GB2040928A (en) | Bicycloalkane derivatives useful as intermediates in preparing pg1 isosteres | |
GB2086381A (en) | 7-oxabicycloheptane derivatives | |
IE54097B1 (en) | Azaprostacyclins, process for their manufacture and their pharmaceutical use | |
KR101986966B1 (en) | How to make Vera Frost | |
SU893130A3 (en) | Method of preparing prostaglandin or their c15 or c9 andt c15 epimers | |
EP0463162B1 (en) | PREPARATION OF 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES | |
GB1569558A (en) | 1-iodo (or chloro)-3-3-protected hydroxy-w-bicycloalkyl-1-alkenes | |
US4089885A (en) | Prostaglandin derivatives | |
EP0134153B1 (en) | Bicyclo[3.3.0]octane derivative and preparation thereof | |
US4021452A (en) | 2,5-Dihydro-2,5-dialkoxyfuran derivatives | |
JP2693615B2 (en) | 1-halo-4,6,10-hexadecatriene compound and method for producing the same | |
US4198430A (en) | 13,14-Dehydro-11-deoxy-prostaglandis | |
GB2033896A (en) | Lithiumaluminium hydride compounds | |
US4644068A (en) | Bicyclo[3.3.0]octenylaldehyde derivatives | |
US4681951A (en) | Bicyclo(3.3.0)octene derivatives | |
US4206127A (en) | 5,6-Dihydro analogues of prostaglandin I2 | |
JPH0739368B2 (en) | 20,20,20-Trifluoroarachidonic acid derivative and method for producing the same | |
DE60024353T2 (en) | Process for producing anti-osteoporic agent | |
EP0100900B1 (en) | Novel (3.2.0.) bicycloheptanone oxime ethers with valuable therapeutic properties | |
CA1250835A (en) | .alpha. CHAIN DIENIC PROSTANOIC ACID DERIVATIVES | |
US4009196A (en) | 2-Acyl-3-substituted cyclopentan-1-ones and process for their preparation | |
EP0362816B1 (en) | Cyclopenteneheptanoic acid derivatives and method of preparation thereof | |
US3952033A (en) | Furan intermediates and process for synthesis of 4-hydroxycyclopetenones, prostaglandin synthesis intermediates | |
EP0255098A1 (en) | Novel 8-(lower alkyl) bicyclo [4.2.0] octane derivatives with valuable therapeutic properties |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |